Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Business Model:
Revenue: $17.4M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Avalo Therapeutics Information
Geographic Data
Address: 540 Gaither Road
City: Rockville
State: MD
Zip: 20850
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$32M
Raised Total:$32M
Social
Metrics
2,472,377Website Global Rank
7,159Website Monthly Traffic
Twitter Followers
Description
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Contact Phone:
+14105228707
Contact Email:
Avalo Therapeutics went public on 11/13/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/13/2015
Ticker Symbol:
AVTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2016 | Equity | $1M | 4/2017 | Post-IPO Equity | $5M | 10/2015 | IPO | $26M | 6/2021 | Debt | $35M |
Horizon Technology Finance Corporation |
2/2023 | Post-IPO Equity | $15M | 9/2021 | Post-IPO Equity | $31.5M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
